검색
Pfizer Inc
PFE관심 목록에 추가
24.480USD
+0.310+1.28%
종가 07/13, 16:00（ET）시세는 15분 지연됩니다
139.52B시가총액
18.59P/E TTM
자세한 내용은 Pfizer Inc 회사
Pfizer Inc. is a research-based, global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, Hympavzi, Sulperazon, Zavicefta, Octagam and others.
Pfizer Inc 정보
종목 코드 PFE
회사 이름Pfizer Inc
상장일Feb 22, 2080
CEOBourla (Albert)
직원 수81000
유형Ordinary Share
회계 연도 종료Feb 22
주소66 Hudson Boulevard East
도시NEW YORK
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가United States of America
우편 번호10001-2192
전화12127332323
웹사이트https://www.pfizer.com/
종목 코드 PFE
상장일Feb 22, 2080
CEOBourla (Albert)
Pfizer Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Albert Bourla, Ph.D.
Dr. Albert Bourla, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
394.63K
+4.08%
Mr. Douglas M. Lankler
Mr. Douglas M. Lankler
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
165.26K
+2.36%
Ms. Sally Susman
Ms. Sally Susman
Executive Vice President, Chief Corporate Affairs Officer
Executive Vice President, Chief Corporate Affairs Officer
95.94K
+7.61%
Mr. Michael (Ike) Mcdermott
Mr. Michael (Ike) Mcdermott
Executive Vice President, Chief Global Supply Officer
Executive Vice President, Chief Global Supply Officer
68.47K
-3.36%
Ms. Lidia L. Fonseca
Ms. Lidia L. Fonseca
Executive Vice President, Chief Digital and Technology Officer
Executive Vice President, Chief Digital and Technology Officer
32.73K
+5.39%
Mr. Ronald E. Blaylock
Mr. Ronald E. Blaylock
Independent Director
Independent Director
32.46K
--
Mr. Aamir Malik
Mr. Aamir Malik
Executive Vice President, Chief US Commercial Officer
Executive Vice President, Chief US Commercial Officer
29.55K
--
Ms. Payal Sahni
Ms. Payal Sahni
Executive Vice President, Chief People Experience Officer
Executive Vice President, Chief People Experience Officer
26.59K
+6.54%
Dr. Scott Gottlieb, M.D.
Dr. Scott Gottlieb, M.D.
Independent Director
Independent Director
10.00K
--
Mr. Cyrus Taraporevala
Mr. Cyrus Taraporevala
Independent Director
Independent Director
10.00K
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Albert Bourla, Ph.D.
Dr. Albert Bourla, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
394.63K
+4.08%
Mr. Douglas M. Lankler
Mr. Douglas M. Lankler
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
165.26K
+2.36%
Ms. Sally Susman
Ms. Sally Susman
Executive Vice President, Chief Corporate Affairs Officer
Executive Vice President, Chief Corporate Affairs Officer
95.94K
+7.61%
Mr. Michael (Ike) Mcdermott
Mr. Michael (Ike) Mcdermott
Executive Vice President, Chief Global Supply Officer
Executive Vice President, Chief Global Supply Officer
68.47K
-3.36%
Ms. Lidia L. Fonseca
Ms. Lidia L. Fonseca
Executive Vice President, Chief Digital and Technology Officer
Executive Vice President, Chief Digital and Technology Officer
32.73K
+5.39%
Mr. Ronald E. Blaylock
Mr. Ronald E. Blaylock
Independent Director
Independent Director
32.46K
--
자주 묻는 질문
Pfizer Inc의 상위 5대 주주는 누구인가요?
Pfizer Inc의 상위 5대 주주는 다음과 같습니다: Dr. Albert Bourla, Ph.D.
Pfizer Inc(PFE)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Pfizer Inc의 주식을 보유한 기관은 총 4824곳이며, 이들이 보유한 주식의 총 가치는 약 3.98B로 전체 발행 주식의 69.87%를 차지합니다. 이는 2025Q4 대비 29483336.00 증가한 수치입니다.
Pfizer Inc의 최대 수익원은 무엇인가요?
2026Q1 기준, Pfizer Inc의 Eliquis alliance revenues and direct sales 부문이 가장 높은 매출을 기록했으며, 금액은 7.96B로 전체 매출의 12.72%를 차지했습니다.